These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 2116226)
61. The interaction of the cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yL)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin. Hasinoff BB Agents Actions; 1989 Mar; 26(3-4):378-85. PubMed ID: 2544086 [TBL] [Abstract][Full Text] [Related]
62. [The effect of superoxide dismutase and catalase on the delayed toxicity of doxorubicin]. Villani F; Galimberti M; Poggi P; Rozza A; Lanza E; Favalli L; Scavini C Cardiologia; 1992 Oct; 37(10):709-11. PubMed ID: 1296877 [TBL] [Abstract][Full Text] [Related]
63. Anti-apoptotic potential of gymnemic acid phospholipid complex pretreatment in Wistar rats with experimental cardiomyopathy. Pathan RA; Bhandari U; Javed S; Nag TC Indian J Exp Biol; 2012 Feb; 50(2):117-27. PubMed ID: 22670474 [TBL] [Abstract][Full Text] [Related]
64. Effects of ICRF-187 on the cardiac and renal toxicity of epirubicin in spontaneously hypertensive rats. Dardir M; Herman EH; Ferrans VJ Cancer Chemother Pharmacol; 1989; 23(5):269-75. PubMed ID: 2495862 [TBL] [Abstract][Full Text] [Related]
65. Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression. Mukherjee S; Banerjee SK; Maulik M; Dinda AK; Talwar KK; Maulik SK BMC Pharmacol; 2003 Dec; 3():16. PubMed ID: 14687418 [TBL] [Abstract][Full Text] [Related]
66. Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats. Herman EH; Zhang J; Ferrans VJ Cancer Chemother Pharmacol; 1994; 35(2):93-100. PubMed ID: 7987999 [TBL] [Abstract][Full Text] [Related]
67. Modulation of glutathione and glutathione dependent antioxidant enzymes in mouse heart following doxorubicin therapy. Gustafson DL; Swanson JD; Pritsos CA Free Radic Res Commun; 1993; 19(2):111-20. PubMed ID: 8225037 [TBL] [Abstract][Full Text] [Related]
68. Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids. Hüsken BC; de Jong J; Beekman B; Onderwater RC; van der Vijgh WJ; Bast A Cancer Chemother Pharmacol; 1995; 37(1-2):55-62. PubMed ID: 7497597 [TBL] [Abstract][Full Text] [Related]
70. [Scavenging of probimane on semiquinone free radical formation by doxorubicin in rat heart]. Zhang Y; Zhang TM; Zhao BL; Han JK; Chen WC; Xin WJ Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):20-3. PubMed ID: 1950578 [TBL] [Abstract][Full Text] [Related]
71. The protective activity of ICRF-187 against doxorubicin-induced cardiotoxicity in the rat. Yeung TK; Jaenke RS; Wilding D; Creighton AM; Hopewell JW Cancer Chemother Pharmacol; 1992; 30(1):58-64. PubMed ID: 1586981 [TBL] [Abstract][Full Text] [Related]